CDC is updating webpages with the term "mpox" to reduce stigma and other issues associated with prior terminology. This change is aligned with the recent World Health Organization decision.
Information For Healthcare Professionals
UpdatedInterim Clinical Considerations for Mpox Vaccination
CDC has updated its Interim Clinical Considerations for using the JYNNEOS and ACAM2000 vaccines during the 2022 U.S. mpox outbreak, including an alternative regimen for administering the JYNNEOS vaccine intradermally.
Caring for Patients
Key Characteristics for Identifying Mpox
CDC urges healthcare providers in the U.S. to be alert for patients who have rash illnesses consistent with mpox.
Prevent and Control Mpox
Vaccine Information
When properly administered before an exposure, vaccines are effective at protecting people against mpox.